Richard E. Kaufman, Senior VP& Chief Operating Officer at Intersect ENT, Inc. (XENT), sold 1,250 shares at $17.25 ($22K) on 2017-04-20, disclosed to the SEC on 2017-04-21.
Scheduled sale ($22k) by Senior VP& Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XENT | SELL | 2018-01-18 | $2.5M | — | Filing → |
| XENT | SELL | 2017-09-27 | $790K | — | Filing → |
| XENT | SELL | 2017-08-29 | $678K | — | Filing → |